The sale reduces the insider’s direct holdings to less than a quarter of their level a year ago, per regulatory disclosure.
A Progyny (NASDAQ:PGNY) director sold 5,500 shares for approximately $137,000 on May 27, 2026, according to an SEC Form 4 filing. The transaction was priced at $24.99 per share, matching the stock’s closing price that day.
Kevin K. Gordon, a company director, has sold 8,000 shares since May 2025, with this latest sale marking his largest single transaction. The move reduces his direct holdings to 20.13% of his pre-sale position, while 15,027 indirect shares remain in a revocable trust.
The filing shows no immediate market reaction, as the sale occurred at the closing price and involved only directly held shares.